Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.

Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S, Lowy DR, Anton-Culver H, Hunter KW.

PLoS Genet. 2007 Nov;3(11):e214. Epub 2007 Oct 16.


Rrp1B gene polymorphism (1307T>C) in metastatic progression of breast cancer.

Nanchari SR, Cingeetham A, Meka P, Damineni S, Tipirisetti N, Padala C, Annamaneni S, Rani Hanumanth S, Digumarthi RR, Satti V.

Tumour Biol. 2015 Feb;36(2):615-21. doi: 10.1007/s13277-014-2613-6. Epub 2014 Oct 3.


The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.

Crawford NP, Yang H, Mattaini KR, Hunter KW.

J Biol Chem. 2009 Oct 16;284(42):28660-73. doi: 10.1074/jbc.M109.023457. Epub 2009 Aug 26.


Metastasis-associated protein ribosomal RNA processing 1 homolog B (RRP1B) modulates metastasis through regulation of histone methylation.

Lee M, Dworkin AM, Lichtenberg J, Patel SJ, Trivedi NS, Gildea D, Bodine DM, Crawford NP.

Mol Cancer Res. 2014 Dec;12(12):1818-28. doi: 10.1158/1541-7786.MCR-14-0167. Epub 2014 Aug 4.


The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.

Crawford NP, Walker RC, Lukes L, Officewala JS, Williams RW, Hunter KW.

Clin Exp Metastasis. 2008;25(4):357-69. doi: 10.1007/s10585-008-9146-6. Epub 2008 Feb 27.


RRP1B is a metastasis modifier that regulates the expression of alternative mRNA isoforms through interactions with SRSF1.

Lee M, Dworkin AM, Gildea D, Trivedi NS; NISC Comparative Sequencing Program, Moorhead GB, Crawford NP.

Oncogene. 2014 Apr 3;33(14):1818-27. doi: 10.1038/onc.2013.133. Epub 2013 Apr 22.


Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.

Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW.

Breast Cancer Res. 2009;11(5):R75. doi: 10.1186/bcr2412. Epub .


BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.

Alsarraj J, Faraji F, Geiger TR, Mattaini KR, Williams M, Wu J, Ha NH, Merlino T, Walker RC, Bosley AD, Xiao Z, Andresson T, Esposito D, Smithers N, Lugo D, Prinjha R, Day A, Crawford NP, Ozato K, Gardner K, Hunter KW.

PLoS One. 2013 Nov 19;8(11):e80746. doi: 10.1371/journal.pone.0080746. eCollection 2013.


Bromodomain 4 activation predicts breast cancer survival.

Crawford NP, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, Lee MP, Ozato K, Hunter KW.

Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6380-5. doi: 10.1073/pnas.0710331105. Epub 2008 Apr 21.


High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.

Riaz M, Sieuwerts AM, Look MP, Timmermans MA, Smid M, Foekens JA, Martens JW.

Breast Cancer Res. 2012 Sep 11;14(5):R123. doi: 10.1186/bcr3317.


Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.

Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR.

BMC Cancer. 2009 Sep 18;9:331. doi: 10.1186/1471-2407-9-331.


Germline polymorphisms are potential metastasis risk and prognosis markers in breast cancer.

Hsieh SM, Lintell NA, Hunter KW.

Breast Dis. 2006-2007;26:157-62. Review.


Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.

Paik JC, Wang B, Liu K, Lue JK, Lin WC.

J Biol Chem. 2010 Feb 26;285(9):6348-63. doi: 10.1074/jbc.M109.072074. Epub 2009 Dec 29.


Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P, Qian X, Hunter KW.

Nat Genet. 2005 Oct;37(10):1055-62. Epub 2005 Sep 4.


A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.

Stein T, Salomonis N, Nuyten DS, van de Vijver MJ, Gusterson BA.

J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):99-116. doi: 10.1007/s10911-009-9120-1. Epub 2009 Apr 30. Review. Erratum in: J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):117-9.


Mouse modifier genes in mammary tumorigenesis and metastasis.

Winter SF, Hunter KW.

J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):337-42. doi: 10.1007/s10911-008-9089-1. Epub 2008 Jul 26. Review.


CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM.

Int J Cancer. 2007 Apr 1;120(7):1434-43.


Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.

Knutson TP, Daniel AR, Fan D, Silverstein KA, Covington KR, Fuqua SA, Lange CA.

Breast Cancer Res. 2012 Jun 14;14(3):R95.


Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.

Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW.

Breast Cancer Res. 2006;8(2):R16. Epub 2006 Mar 21.


JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.

Li LL, Xue AM, Li BX, Shen YW, Li YH, Luo CL, Zhang MC, Jiang JQ, Xu ZD, Xie JH, Zhao ZQ.

Breast Cancer Res. 2014 May 30;16(3):R56. doi: 10.1186/bcr3667.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk